Medicover AB 2025 AR2
The report highlights Medicover's performance in 2025, marking its 30th anniversary with continued growth, improved profitability, and strong cash generation. The company achieved double-digit organic revenue growth of 12.7% and successfully exceeded its mid-term financial targets for 2025. Key milestones included the major acquisitions of CityFit in Poland and SYNLAB's laboratory businesses in Central and Eastern Europe. Additionally, Medicover's near-term and long-term climate targets were validated by the Science Based Targets initiative (SBTi), committing to a 42% reduction in absolute scope 1 and 2 emissions by 2030.
Company: Medicover AB
Sector: Professional & technical services
Country: Sweden
Year: 2025
Type: AR2
Pages: 196
Medicover AB
The report highlights Medicover's performance in 2025, marking its 30th anniversary with continued growth, improved profitability, and strong cash generation. The company achieved double-digit organic revenue growth of 12.7% and successfully exceeded its mid-term financial targets for 2025. Key milestones included the major acquisitions of CityFit in Poland and SYNLAB's laboratory businesses in Central and Eastern Europe. Additionally, Medicover's near-term and long-term climate targets were validated by the Science Based Targets initiative (SBTi), committing to a 42% reduction in absolute scope 1 and 2 emissions by 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2025
Reporting Period
Jan 1, 2025 - Dec 31, 2025
Fiscal Year
2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees